Patient Support Services Contact Us
Image: Coherus Investors

Snapshot

Revenue & Earnings

Revenue (FY) $211.04
EBIT (Mil) (FY) $-256.88
EBIT (Mil) (MRQ) $-32.64
EBIT (Mil) (TTM) $-227.43
EBITDA (Mil) (FY) $-253.18
EBITDA (Mil) (MRQ) $-31.76
EBITDA (Mil) (TTM) $-223.56
Net Income Excluding Extraordinary Items (Mil) (FY) $-291.75
Net Income Including Extraordinary Items (Mil) (FY) $-291.75
Diluted EPS Excluding Extraordinary Items (FY) $-3.76
Diluted EPS Including Extraordinary Items (FY) $-3.76

Dividends

Yield (%) --
Dividend Record Date
Dividend Rate --

Ratios

Price to Revenue (TTM) $2.64
Price to Revenue (MRQ) $2.04
Price to Revenue (FY) $2.27
Price To Cash Flow (TTM) --
Price to Cash Flow (MRQ) --
Price to Cash Flow (FY) --
Price to Book (MRQ) --
Price to Book (FY) --
Total Debt to Equity (MRQ) (%) --%
Total Debt to Equity (FY) (%) --%
Current Ratio (MRQ) $2.28
Current Ratio (FY) $2.75

Growth

5-Year Annual Dividend Growth Rate (%) --%
5-Year Annual Revenue Growth Rate (%) 166.98%

FY = Fiscal Year. MRQ = Most Recent Quarter. mil = Millions. TTM = Trailing Twelve Months.

Copyright Refinitiv